Page last updated: 2024-09-04

pomalidomide and cyclin d1

pomalidomide has been researched along with cyclin d1 in 1 studies

Compound Research Comparison

Studies (pomalidomide)	Trials (pomalidomide)	Recent Studies (post-2010) (pomalidomide)	Studies (cyclin d1)	Trials (cyclin d1)	Recent Studies (post-2010) (cyclin d1)
623	121	552	10,885	70	5,157

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Body, S; Bourgeais, J; Bustany, S; Gouilleux, F; Hérault, O; Sola, B; Tchakarska, G	1

Other Studies

1 other study(ies) available for pomalidomide and cyclin d1

Article	Year
Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells. Oncotarget, 2016, 07-19, Volume: 7, Issue:29 Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Chemokines; Cyclin D1; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Humans; Multiple Myeloma; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Thalidomide; Tumor Microenvironment	2016

Article

Year

Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells.

Oncotarget, 2016, 07-19, Volume: 7, Issue:29

Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Chemokines; Cyclin D1; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Humans; Multiple Myeloma; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Thalidomide; Tumor Microenvironment

2016